Counterfeit Drug Industry: The Role of Comple...

The buzz: “Although counterfeit drug production was originally concerned with lifestyle medications treating non-life threatening conditions, the industry has expanded to produce nearly every type of medicine” (cnbc.com/id/44759526). The World Health Organization (WHO) estimates ...  Show more

The buzz: “We thought big data was big, but the potential quantization and tracking and administration of all classes of activity and reality via blockchain technology…hints at the next orders-of-magnitude...” (Melanie Swan). Based its hyped ability to drive end-to-end value, eli ...  Show more

If you had a rare disease and the only drug that could help you suddenly shot up in price how would you feel? What if your health service or insurer decided it was too expensive and they wouldn’t fund it any more? This is the problem facing some patients in the Netherlands.In ord ...  Show more

As prescription drug costs skyrocket in the US, thousands of people are forced to forgo lifesaving medications -- all while manufacturers and health care facilities systematically destroy perfectly good, surplus pills. Kiah Williams shares how SIRUM -- a nonprofit that delivers u ...  Show more

We chronicle the epic struggle to get drugs that treat very rare diseases on the market, and the unintended consequence of that fight, which affected the cost of all kinds of drugs. This is a strange story that involves a hit 70s TV show, a fake march on Washington, a courageo ...

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...